Company news

United Therapeutics Corporation news in 2021

United Therapeutics Corporation's news releases, calls and decks from 2021, newest first.

View company

United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst

December 29, 2021

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022

December 2, 2021

United Therapeutics Corporation Reports Third Quarter 2021 Financial Results

November 2, 2021

United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference

October 31, 2021

United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021

October 26, 2021

3D Systems and United Therapeutics Announce Expansion of Bioprinting Program

October 26, 2021

United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021

October 20, 2021

United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application

October 17, 2021

United Therapeutics to Present New Data at CHEST Annual Meeting 2021

October 10, 2021

United Therapeutics Converts to a Public Benefit Corporation Following Shareholder Approval

September 29, 2021

United Therapeutics Releases its Annual Corporate Responsibility Report

September 9, 2021

United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021

September 6, 2021

United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month

August 24, 2021

United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021

August 23, 2021

United Therapeutics Corporation Reports Second Quarter 2021 Financial Results

August 3, 2021

United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference

August 2, 2021

United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021

July 27, 2021

United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study

June 29, 2021

United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review

June 15, 2021

MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA

June 15, 2021

United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia

June 6, 2021

United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary Fibrosis

June 2, 2021

United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference

May 24, 2021

United Therapeutics Corporation Reports First Quarter 2021 Financial Results

May 4, 2021

United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021

April 25, 2021

United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA

April 18, 2021

Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA

April 18, 2021

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

March 31, 2021

United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa Valley Forum

March 23, 2021

United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference

March 8, 2021

United Therapeutics Corporation To Present At The 41st Annual Cowen Health Care Conference

February 23, 2021

United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 Financial Results

February 23, 2021

United Therapeutics Corporation To Report Fourth Quarter And Full Year 2020 Financial Results Before The Market Opens On Wednesday, February 24, 2021

February 16, 2021

United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin®

February 9, 2021

United Therapeutics Announces BREEZE Study of Investigational Tyvaso DPI™ Meets Primary Objective

January 27, 2021

3D Systems Announces Breakthrough in Bioprinting Technology and Expansion of Regenerative Medicine Initiative

January 26, 2021

United Therapeutics Announces New England Journal of Medicine Publication of the INCREASE Study Evaluating Tyvaso® in Pulmonary Hypertension Associated with Interstitial Lung Disease

January 12, 2021

United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference

January 3, 2021

Calls in 2021

Decks in 2021